RxDoctor Payments Data

Christina Vidanez

Primary Care · Northridge, CANPI 1740827872

Payments from drug & device makers

$3,098in general payments, 2019–2025

Across 149 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$758
  • IBSA Pharma Inc.$650
  • Medtronic$537
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$356
  • Vertex$244
  • Boston Scientific$127
  • plus $426 from 11 others

What the payments were for

  • Travel & lodging$35611%
  • Food & beverage$2,69787%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,098 in reported general payments places this provider in the 90th percentile of 706 primary care providers in California.

See all primary care providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl68$50,260
Diclofenac Sodium83$29,611
LicartDiclofenac Epolamine39$28,060
ZtlidoLidocaine24$24,565
Buprenorphine74$16,607
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen519$9,770
MovantikNaloxegol Oxalate17$6,636
Lidocaine46$5,032
Pregabalin69$3,186
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl15$2,945
Oxycodone Hcl129$2,895
Naloxone Hcl40$1,975
Gabapentin208$1,788
Morphine Sulfate ErMorphine Sulfate67$1,565
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen61$1,192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$758$50,26068 claims
IBSA Pharma Inc.Licart$650$28,06039 claims
Scilex Pharmaceuticals Inc.Ztlido$50$24,56524 claims
Redhill Biopharma Inc.Movantik$21$6,63617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 706 primary care providers in California.

Other primary care in Northridge

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →